Common Stock, Shares, Issued of VBI Vaccines Inc/BC from 31 Dec 2015 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
VBI Vaccines Inc/BC quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2015 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Common Stock, Shares, Issued for the quarter ending 31 Mar 2024 was 25,236,766, a 193% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 25,236,766 +16,628,227 +193% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 23,918,983 +15,310,444 +178% 31 Dec 2023 10-Q 15 May 2024 2024 Q1
Q3 2023 23,339,220 -234,918,274 -91% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 8,608,539 -249,648,955 -97% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 8,608,539 -249,648,955 -97% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 8,608,539 -249,641,734 -97% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 258,257,494 +952,726 +0.37% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 258,257,494 +3,112,356 +1.2% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 258,257,494 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 258,250,273 +11,211,263 +4.5% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 257,304,768 +15,265,288 +6.3% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 255,145,138 +24,496,742 +11% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q4 2020 247,039,010 +68,781,811 +39% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 242,039,480 +63,782,281 +36% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 230,648,396 +132,891,197 +136% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 178,375,670 +80,713,783 +83% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 178,257,199 +80,913,422 +83% 31 Dec 2019 10-Q 02 Nov 2020 2020 Q3
Q3 2019 178,257,199 +113,873,808 +177% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 97,757,199 +33,373,808 +52% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 97,661,887 +33,446,160 +52% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 97,343,777 +33,264,996 +52% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 64,383,391 +24,154,020 +60% 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 64,383,391 +24,154,020 +60% 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 64,215,727 +24,155,105 +60% 31 Mar 2018 10-Q 01 May 2018 2018 Q1
Q4 2017 64,078,781 +24,060,286 +60% 31 Dec 2017 10-K 25 Feb 2019 2018 FY
Q3 2017 40,229,371 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 40,229,371 30 Jun 2017 10-Q 31 Jul 2017 2017 Q2
Q1 2017 40,060,622 +21,145,512 +112% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 40,018,495 +21,103,385 +112% 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q1 2016 18,915,110 29 Apr 2016 10-K 20 Mar 2017 2016 FY
Q4 2015 18,915,110 31 Dec 2015 10-K 20 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.